TrialBlood advances2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
Anita Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papertrialcites it
TrialBlood advances2018
Anita Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.